File(s) under permanent embargo
Glycopeptides and antibiotics for Gram-Positive Bacterial Infections
Glycopeptides, lipopetides and other antibiotics such as linezolid and quinupristin/dalfopristin, are exclusively used for the treatment of infections caused by Gram-Positive Bacteria. Limited information is available about the dosing of these antibiotics in obese patients. This chapter aims to summarise the available evidence on the dosing of glycopeptides, lipopeptides, linezolid and quinupristin/dalfopristin in obesity. Specific dosing recommendations are also provided to aid clinical decisions making with regards to dosing of these antibiotics in obese patients.
History
Publication title
Drug Dosing in Obesity - Volume 1: AntimicrobialsEdition
1stEditors
STR Zaidi & JA RobertsPagination
63-76ISBN
978-3-319-44034-7Department/School
School of Pharmacy and PharmacologyPublisher
SpringerPlace of publication
SwitzerlandExtent
11Rights statement
Copyright 2016 Springer International Publishing SwitzerlandRepository Status
- Restricted